Effect of cross-fostering on renal anti-oxidant/oxidant status and development of hypertension in spontaneously hypertensive rats

• Published in: Clinical and Experimental Pharmacology and Physiology
• Main Author: Lee S.K.; Sirajudeen K.N.S.; Sundaram A.; Zakaria R.; Singh H.J.
• Format: Article
• Language: English
• Published: 2011
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-82355194922&doi=10.1111%2fj.1440-1681.2011.05624.x&partnerID=40&md5=fe9a107e49b03563cd8468b72d504e50

1.The hypotensive effect of cross-fostering in spontaneously hypertensive rats (SHR) is thought to involve adjustments in renal function. However, its association with renal anti-oxidant/oxidant balance during cross-fostering is not known. 2.The present study examined the effect of cross-fostering and in-fostering of 1-day-old offspring between SHR and Wistar-Kyoto (WKY) dams on renal anti-oxidant/oxidant status and systolic blood pressure (SBP). Renal anti-oxidant/oxidant status and SBP were determined in the offspring from 4-16weeks of age. 3.Cross-fostered SHR had significantly lower SBP than in-fostered SHR at 6, 8 and 12weeks, but not at 16weeks (127±1 vs 144±2, 138±1 vs 160±1, 174±2 vs 184±2 and 199±2 vs 194±3mmHg at 6, 8, 12 and 16weeks, respectively). No differences in SBP were evident between cross-fostered and in-fostered WKY rats. There were no significant differences in levels of thiobarbituric acid-reactive substances (TBARS), protein carbonyl and total anti-oxidant status (TAS) or superoxide dismutase, catalase, glutathione peroxidase (GPx), glutathione S-transferase and glutathione reductase activity between cross-fostered and in-fostered SHR or WKY offspring. However, compared with WKY rats, catalase activity was higher at 6 and 16weeks, TAS was higher at 16weeks and GPx activity and TBARS were lower at 16weeks in SHR. 4.It appears that cross-fostering of SHR offspring to WKY dams during the early postnatal period causes a transient delay in the rise in blood pressure in SHR and that this does not involve the renal anti-oxidant/oxidant system. © 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.